UC Blue Ash express application events offer free, easy way to apply

The University of Cincinnati Blue Ash College will host two upcoming events designed to make the application process fast, convenient and free for prospective students.

The UC Blue Ash College express application events are set for Sunday, May 5, and Sunday, June 2. Both events run from 2-4 p.m. in Muntz Hall.

The express application event is similar to an open house, but on a smaller scale. The $50 application fee will be waived for prospective students who apply during the event.

You can also take a self-guided tour of the campus, meet with admissions representatives and learn more about the 50 academic programs UC Blue Ash offers.

“This is a little more personal version of our open house,” says Brad Tate, the college's director of admissions. “It’s a great way to see our beautiful campus and really get a feel for our college and everything we offer.”

Register in advance online. Walk-ins will also be welcome on the day of the event. For more information, call 513-745-5700 or send an email to admissions@ucblueash.edu.

Related Stories

1

Recent advances may speed time to endometriosis diagnosis

March 16, 2026

The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.

3

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.